MedTrace Logo

Risk Stratification Oriented Treatment of Pediatric Ewing Sarcoma: a Prospective Multicenter Cohort Study

NCT06451302 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-06-11

No results posted yet for this study

Summary

The aim is to evaluate the outcome and safety of risk-stratification oriented treatment for pediatric Ewing sarcoma in multicenters .

Conditions

  • Ewing Sarcoma
  • Risk Stratification

Interventions

DRUG

cyclophosphamide, adriamycin, vincristine，Ifosfamide，etoposide

The doses and intensity of chemotherapy vary according to risk stratification. Mainenance therapy is added to high-risk patients.

Sponsors & Collaborators

  • Yizhuo Zhang

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-17
Primary Completion
2027-05-31
Completion
2027-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06451302 on ClinicalTrials.gov